Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Time from R&D start to approval of select cancer drugs 2017

Time between R&D start and approval of selected cancer drugs on the market as of 2017 (in years)

Time from R&D start to approval of select cancer drugs 2017 This statistic shows the time between the R&D start and the approval of selected cancer drugs which were on the market as of 2017. Alexion Pharmaceuticals' drug Eculizumab had a research and development phase of over 15 years until its approval in March 2007.
Show more

Time between R&D start and approval of selected cancer drugs on the market as of 2017 (in years)

Drug name (company, R&D start date)Time between R&D start and approval in years
--
--
--
--
--
--
--
--
--
--
Drug name (company, R&D start date)Time between R&D start and approval in years
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Download Settings Share
Download started
Please be patient - this may take a moment
This statistic shows the time between the R&D start and the approval of selected cancer drugs which were on the market as of 2017. Alexion Pharmaceuticals' drug Eculizumab had a research and development phase of over 15 years until its approval in March 2007.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Oncology"
  • Cancer facts
  • Oncology market
  • Companies
  • Cancer drugs
  • Research and development
The most important statistics
  • Immuno-oncology
  • Treatment types
  • Physicians and patients
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.